Larkin Finbar 4
4 · Jazz Pharmaceuticals plc · Filed Nov 10, 2020
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Development
Transactions
- Sale
Ordinary Shares
2020-11-06$151.93/sh−197$29,930→ 13,964 total
Footnotes (1)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.